CO5011059A1 - Antibioticos de quinolona magnesica - Google Patents

Antibioticos de quinolona magnesica

Info

Publication number
CO5011059A1
CO5011059A1 CO98071196A CO98071196A CO5011059A1 CO 5011059 A1 CO5011059 A1 CO 5011059A1 CO 98071196 A CO98071196 A CO 98071196A CO 98071196 A CO98071196 A CO 98071196A CO 5011059 A1 CO5011059 A1 CO 5011059A1
Authority
CO
Colombia
Prior art keywords
quinolona
magnesica
antibiotics
solution
compounds
Prior art date
Application number
CO98071196A
Other languages
English (en)
Inventor
Karen Barsuhn
Ching-Chiang Su
K Frank Rodney
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CO5011059A1 publication Critical patent/CO5011059A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una solución que comprende los compuestos descritos a continuación, de fórmula I, en donde los compuestos están en solución con iones Mg+2, en una relación de proporciones del ion Mg+2 a compuesto de 1:4 a 3:1 partes,
CO98071196A 1997-12-05 1998-12-01 Antibioticos de quinolona magnesica CO5011059A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6782997P 1997-12-05 1997-12-05

Publications (1)

Publication Number Publication Date
CO5011059A1 true CO5011059A1 (es) 2001-02-28

Family

ID=22078690

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98071196A CO5011059A1 (es) 1997-12-05 1998-12-01 Antibioticos de quinolona magnesica

Country Status (8)

Country Link
US (1) US6288080B1 (es)
AR (1) AR017812A1 (es)
AU (1) AU1796799A (es)
CO (1) CO5011059A1 (es)
ID (1) ID21415A (es)
PE (1) PE132299A1 (es)
WO (1) WO1999029322A1 (es)
ZA (1) ZA9810994B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030171340A1 (en) * 2002-02-07 2003-09-11 Jenefir Isbister Methods of disease treatment using metal-complexed tetracycline antibiotics
EP1764102A4 (en) * 2004-07-02 2010-08-25 Daiichi Seiyaku Co MEDICINAL COMPOSITION CONTAINING QUINOLONE
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
MX345158B (es) 2008-10-07 2017-01-18 Raptor Pharmaceuticals Inc Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
HUE050147T2 (hu) 2008-10-07 2020-11-30 Horizon Orphan Llc Tüdõgyulladás csökkentése levofloxacin belélegzése útján
AU2010289326B2 (en) 2009-09-04 2015-09-24 Horizon Therapeutics U.S. Holding Llc Use of aerosolized levofloxacin for treating cystic fibrosis
EP3305294A4 (en) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE
WO2016195020A1 (ja) * 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
CA2988092A1 (en) * 2015-06-02 2016-12-08 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid formulation
ES2886088T3 (es) 2017-02-13 2021-12-16 Bayer Animal Health Gmbh Composición líquida que contiene pradofloxacina

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730000A (en) 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
DE3517709A1 (de) 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3635062A1 (de) 1986-10-15 1988-04-21 Bayer Ag Neue metallsalze von 1-cyclopropyl-chinoloncarbonsaeuren und diese enthaltende arzneimittel
DE3902079A1 (de) 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5225413A (en) 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids
JP2832535B2 (ja) * 1989-04-04 1998-12-09 富山化学工業株式会社 キノロンカルボン酸またはその塩の可溶化法
EP0507851B1 (en) 1989-12-29 1997-04-02 Abbott Laboratories Quinolone carboxylic acid--metal ion--acid complexes
US5084276A (en) 1990-01-05 1992-01-28 Abbott Laboratories Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
FR2665635A1 (fr) 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
US5258528A (en) * 1990-11-30 1993-11-02 Warner-Lambert Company Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group
GB9118183D0 (en) 1991-08-23 1991-10-09 Solanki Kishor K Imaging of infections
ATE162081T1 (de) 1991-09-17 1998-01-15 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
US5290794A (en) 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US5363155A (en) * 1993-02-18 1994-11-08 Ehud Urinowski Eye examination apparatus and accessory therefor
US5519843A (en) 1993-03-15 1996-05-21 M-Systems Flash memory system providing both BIOS and user storage capability
IL109626A0 (en) 1993-05-15 1994-08-26 Abbott Lab Stable quinolone and naphthydridine premix formulations
CA2239352C (en) * 1995-12-21 2002-06-04 Pfizer Inc. Injectable quinolone formulations
ES2188940T3 (es) * 1996-05-10 2003-07-01 Upjohn Co Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas.

Also Published As

Publication number Publication date
ID21415A (id) 1999-06-10
AR017812A1 (es) 2001-10-24
US6288080B1 (en) 2001-09-11
WO1999029322A1 (en) 1999-06-17
AU1796799A (en) 1999-06-28
PE132299A1 (es) 1999-12-21
ZA9810994B (en) 2000-06-01

Similar Documents

Publication Publication Date Title
CO5011059A1 (es) Antibioticos de quinolona magnesica
GT199900040A (es) Biciclo [2.2.1] heptanos y compuestos relacionados.
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
ES2192201T3 (es) Compuestos de piranona utiles para el tratamiento de infecciones retrovirales.
ES2162198T3 (es) Agentes estrogenos.
NZ330843A (en) The use of a chelating agent in a peroxygen bleach containing composition to improve disinfecting properties
IT1226726B (it) Composti attivi come inibitori della biosintesi del colesterolo.
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
BR0114252A (pt) Derivados de nitrosodifenilamina
NO20010228L (no) Farmasøytiske preparater omfattende 2-kinoloner
ES2150434T3 (es) Acondicionador para el aclarado.
ATE234625T1 (de) Glp-1 zusammensetzungen mit verlängerter wirkdauer
YU30292A (sh) Nova aktivna jedinejnja
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
ES8403472A1 (es) Procedimiento para la obtencion de un medio para combatir las pestes a base de como minimo de aminocetal.
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
SE9904507D0 (sv) New compounds
ES2107788T3 (es) Aldonamidas y su uso como tensioactivos.
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
ES2156633T3 (es) Derivados del acido tiazolidina-4-carboxilico como agentes citoprotectores.
MX9305171A (es) Derivados de indazol.
BR0009453A (pt) Processo para a preparação de um composto
AU5390900A (en) Potassium channel blocking agents
ES2162101T3 (es) Nitrilo.
MY102186A (en) Antitumor anthracycline glycosides, their preparation intermediate thereof, and compositions and use thereof